Position paper of the EPMA and EFLM: a global vision of the consolidated promotion of an integrative medical approach to advance health care

EPMA Journal

Vincenzo Costigliola³  Maurizio Ferrari⁴  Sverre Sandberg¹  Elizabeta Topic¹  Ian D Watson¹  Olga Golubnitschaja² 

[1] European Federation of Clinical Chemistry and Laboratory Medicine, Liverpool, L9 7AL, UK;European Association for Predictive, Preventive and Personalised Medicine, EPMA, Brussels 1150, Belgium;European Medical Association, Brussels, 1160, Belgium;European Society of Predictive Medicine, Milan, 20159, Italy

关键词: Expert recommendations;    Education;    Ethics;    Economy;    Bioinformatics;    Patient in focus;    Health care;    Integrative medical record;    Predictive preventive and personalised medicine;    Laboratory medicine;   

Others  :  801763
DOI  :  10.1186/1878-5085-4-12

 received in 2013-02-14, accepted in 2013-04-09,  发布年份 2013

【 摘 要 】

The authors consider acute problems in the quality and management of medical services challenging health care systems worldwide. This actuality has motivated the representatives of the European Association for Predictive, Preventive and Personalised Medicine and European Federation of Clinical Chemistry and Laboratory Medicine to consider the efforts in promoting an integrative approach based on multidisciplinary expertise to advance health care. The current paper provides a global overview of the problems related to medical services: pandemic scenario in the progression of common chronic diseases, delayed interventional approaches of reactive medicine, poor economy of health care systems, lack of specialised educational programmes, problematic ethical aspects of treatments as well as inadequate communication among professional groups and policymakers. Further, in the form of individual paragraphs, the article presents a consolidated position of the represented European organisations. This position is focused on the patients' needs, expert recommendations for the relevant medical fields and plausible solutions which have a potential to advance health care services if the long-term strategies were to be effectively implemented as proposed here.

【 授权许可】

   
2013 Golubnitschaja et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Costigliola V, Gahan P, Golubnitschaja O: Predictive medicine as the new philosophy in health care. In Predictive diagnostics and personalized treatment: Dream or Reality. Edited by Golubnitschaja O. New York: Nova Science Publishers; 2009:1-3.
• [2]Golubnitschaja O, Yeghiazaryan K, Costigliola V, Trog D, Braun M, Debald M, Kuhn W, Schild HH: Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon? EPMA J 2013, 4(1):6.
• [3]Golubnitschaja O: Three levels of prediction, prevention and individualised treatment algorithms to advance diabetes care: integrative approach. In New Strategies to Advance Pre/Diabetes Care: Integrative Approach by PPPM. Edited by Mozaffari M, Golubnitschaja O. London: Springer; 2013:15-28. [Golubnitschaja O (Series Editor): Advances in Predictive, Preventive and Personalised Medicine, vol 3.]
• [4]Golubnitschaja O: Clinical proteomics in application to predictive diagnostics and personalized treatment of diabetic patients. Current Proteomics 2008, 5:35-44.
• [5]Golubnitschaja O, Jaksche A, Moenkemann H, Yeghiazaryan K, Karl SE, Schild HH, Löffler KU: Molecular imaging system for possible prediction of active retinopathy in patients with diabetes mellitus. Amino Acids 2005, 28:229-237.
• [6]Carlsen S, Petersen PH, Skeie S, Skadberg Ø, Sandberg S: Within-subject biological variation of glucose and HbA(1c) in healthy persons and in type 1 diabetes patients. Clin Chem Lab Med 2011, 49(9):1501-1507.
• [7]Kapalla M, Matuskova D: Information systems as an essential component of prediction in the laboratory diagnostics. In Predictive Diagnostics and Personalized Treatment: Dream or Reality. Edited by Golubnitschaja O. New York: Nova Science Publishers; 2009:529-548.
• [8]Golubnitschaja O: Changing long-held beliefs is never easy: a proposal for multimodal approaches in female healthcare – an integrative view. In Healthcare Overview: New Perspectives. Edited by Costigliola V, Golubnitschaja O. London: Springer; 2012:251-268. [Golubnitschaja O (Series Editor): Advances in Predictive, Preventive and Personalised Medicine, vol 1.]
• [9]Costigliola V: Mobility of medical doctors as an attribute of the cross-border healthcare: challenges, opportunities and perspectives. In Healthcare Overview: New Perspectives. Edited by Costigliola V, Golubnitschaja O. London: Springer Dordrecht Heidelberg; 2012:233-244. [Golubnitschaja O (Series Editor): Advances in Predictive, Preventive and Personalised Medicine, vol 1.]
• [10]Mandel S, Golubnitschaja O: Time for new guidelines in handling of neurodegenerative disorders: optimistic versus pessimistic prognosis by application of PPPM. In Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future. Edited by Mandel S. London: Springer; 2013:3-9. [Golubnitschaja O (Series Editor): Advances in Predictive, Preventive and Personalised Medicine, vol 2.]
• [11]Skeie S, Kristensen GB, Carlsen S, Sandberg S: Self-monitoring of blood glucose in type 1 diabetes patients with insufficient metabolic control: focused self-monitoring of blood glucose intervention can lower glycated hemoglobin A1C. J Diabetes Sci Technol 2009, 3(1):83-88.
• [12]Society for Participatory Medicine [http://participatorymedicine.org webcite]
• [13]Golubnitschaja O, Costigliola V, EPMA: General report & recommendations in predictive, preventive and personalised medicine 2012: White Paper of the European Association for Predictive, Preventive and Personalised Medicine. EPMA J 2012, 3:14.
• [14]Golubnitschaja O, Swanton C, Danesi R, Costigliola V: Promoting predictive, preventive and personalised medicine: European event of global importance. EPMA J 2011, 2(2):131-136.
• [15]Kapalla M: Healthcare information complexity and the role of informatics in predictive, preventive and personalized medicine. In Personalisierte Medizin und Informationstechnologie. 15th edition. Edited by Niederlag W, Lemke HU, Rienhoff O. Dresden: Health Academy; 2010:83-108.
• [16]Shapira N: A gender-specific nutritional approach to women’s healthcare. In Healthcare Overview: New Perspectives. Edited by Costigliola V, Golubnitschaja O. London: Springer; 2012:269-305. [Golubnitschaja O (Series Editor): Advances in Predictive, Preventive and Personalised Medicine, vol 1.]
• [17]Marcus-Kalish M, Meiri H: Simultaneous systematic approach to enable predictive, preventive and personalised medicine - women healthcare as a case study. In Healthcare Overview: New Perspectives. Edited by Costigliola V, Golubnitschaja O. London: Springer; 2012:313-331. [Golubnitschaja O (Series Editor): Advances in Predictive, Preventive and Personalised Medicine, vol 1.]
• [18]Gefenas E, Cekanauskaite A, Tuzaite E, Dranseika V, Characiejus D: New ethical paradigm in preventive, predictive and personalised medicine. In Healthcare Overview: New Perspectives. Edited by Costigliola V, Golubnitschaja O. London: Springer; 2012:471-484. [Golubnitschaja O (Series Editor): Advances in Predictive, Preventive and Personalised Medicine, vol 1.]
• [19]Drucker E, Krapfenbauer K: Pitfalls and limitations in translation from biomarker discovery to clinical utility in personalised medicine. EPMA J 2013, 4(1):7.
• [20]Kanavos P, Sullivan R, Lewison G, Schurer W, Eckhouse S, Vlachopioti Z: The role of funding and policies on innovation in cancer drug development. Ecancer 2010, 4:164.
• [21]The EPMA Journal [http://www.epmajournal.com/ webcite]
• [22]Golubnitschaja O: Advances in Predictive, Preventive and Personalised Medicine. [http://www.springer.com/series/10051 webcite]
• [23][http://www.youtube.com/watch?v=SOwVS2Hh0KY]